## Overview
A headache (ICD-10: R51) is one of the most common pain complaints worldwide. It is broadly defined as any pain in the region of the head or upper neck and can range from a mild, dull ache to a severe, debilitating episode that disrupts daily life. According to the Global Burden of Disease Study, tension-type headache and migraine rank among the top ten causes of disability globally, affecting more than 3 billion individuals each year [1]. In the United States alone, headaches account for approximately 2% of all emergency department visits and are the fourth most common reason adults present to primary care clinics.
People search for headache information for several reasons: to determine whether their headache is "normal" or a sign of something serious, to find effective self-care strategies, and to decide whether they need to see a physician. Because the differential diagnosis of headache spans from benign tension-type headache to life-threatening conditions such as subarachnoid hemorrhage, accurate, evidence-based guidance is essential.
This article provides a comprehensive, clinician-reviewed overview of headache — including common causes, red-flag warning signs, self-care measures, over-the-counter and prescription options, relevant lab tests, considerations for special populations, and clear guidance on when to escalate care.
## Common Causes
The International Classification of Headache Disorders, 3rd edition (ICHD-3), categorizes headaches into primary headache disorders (no underlying structural cause) and secondary headaches (resulting from another condition) [2]. Below are the most common causes, ranked roughly by prevalence.
### Primary Headaches
**1. Tension-type headache (TTH)**
TTH is the most prevalent primary headache, affecting up to 78% of the general population at some point. The pain is typically bilateral, pressing or tightening in quality ("band-like"), mild to moderate in intensity, and lasts 30 minutes to several days. The pathophysiology is not fully understood but is thought to involve peripheral myofascial nociception (pericranial muscle tenderness) in the episodic form and central sensitization of pain pathways in the chronic form [3]. Stress, poor posture, sleep deprivation, and eye strain are common triggers.
**2. Migraine**
Migraine affects roughly 12–15% of adults and is three times more common in women than men. It is characterized by moderate-to-severe unilateral, pulsating pain lasting 4–72 hours, often accompanied by nausea, vomiting, photophobia, and phonophobia. Approximately one-third of migraine patients experience aura — transient visual, sensory, or language disturbances preceding the headache. The current understanding of migraine pathophysiology centers on cortical spreading depression (for aura) and activation of the trigeminovascular system, with calcitonin gene-related peptide (CGRP) playing a key role in pain signaling [2].
**3. Cluster headache**
Cluster headache is less common (prevalence ~0.1%) but extremely severe. It presents as strictly unilateral, orbital or periorbital stabbing pain lasting 15–180 minutes, occurring in clusters (bouts) of weeks to months. Ipsilateral autonomic features — lacrimation, conjunctival injection, nasal congestion, ptosis — are hallmark features. Hypothalamic activation is believed to drive the circadian and circannual periodicity.
**4. Medication-overuse headache (MOH)**
MOH arises when acute headache medications (analgesics, triptans, opioids, or combination agents) are used ≥10–15 days per month for more than 3 months. Paradoxically, the very medications intended to relieve headache perpetuate a cycle of chronic daily headache through central sensitization and altered pain modulation.
### Secondary Headaches
**5. Cervicogenic headache**
Originating from structures in the cervical spine (facet joints, intervertebral discs, upper cervical nerve roots), cervicogenic headache typically presents as unilateral pain radiating from the neck to the frontal or temporal region, often aggravated by neck movement or sustained postures.
**6. Sinus headache**
True sinus headache results from acute bacterial or viral sinusitis, presenting as facial pressure and pain over the affected sinus, worsened by bending forward, and accompanied by nasal congestion, purulent discharge, and sometimes fever. It is important to note that many self-diagnosed "sinus headaches" are actually migraine — studies suggest up to 88% of patients presenting with a sinus headache meet ICHD criteria for migraine [2].
**7. Systemic and metabolic causes**
Headache may be secondary to fever, dehydration, hypoglycemia, hypertension (particularly hypertensive emergency with systolic >180 mmHg), anemia, caffeine withdrawal, carbon monoxide exposure, or viral infection. In these cases, treating the underlying condition generally resolves the headache.
**8. Serious intracranial causes**
Though uncommon, headache may signal subarachnoid hemorrhage, meningitis, brain tumor, cerebral venous sinus thrombosis, giant cell arteritis, or acute-angle-closure glaucoma. These conditions require emergent evaluation.
## RED FLAGS
The following warning signs — sometimes recalled with the mnemonic **SNOOP4** — warrant immediate medical evaluation (emergency department or call 911/112) [6]:
- **"Thunderclap" headache** — sudden, severe headache reaching maximum intensity within seconds to one minute (suggests subarachnoid hemorrhage until proven otherwise)
- **Worst headache of your life** — especially if different from prior headaches
- **New headache after age 50** — raises suspicion for giant cell arteritis, mass lesion, or other secondary cause
- **Headache with fever, stiff neck, and rash** — classic triad of meningitis
- **Headache with neurological deficits** — weakness, numbness, vision loss, speech difficulty, confusion, seizure, or altered consciousness
- **Headache after head trauma** — even mild, especially if worsening or associated with vomiting or drowsiness
- **Headache with papilledema** — swelling of the optic disc suggesting raised intracranial pressure
- **Progressive headache** worsening over days to weeks, especially if worse in the morning or aggravated by Valsalva maneuver (coughing, straining)
- **Headache in an immunocompromised patient** — HIV, organ transplant, chemotherapy
- **Headache with eye redness, halos around lights, and reduced vision** — may indicate acute-angle-closure glaucoma
- **New headache during pregnancy or postpartum** — may indicate pre-eclampsia, cerebral venous thrombosis, or posterior reversible encephalopathy syndrome (PRES)
> **Important:** If any of these red flags are present, do NOT attempt self-treatment. Seek emergency medical care immediately.
## Self-Care at Home
For mild-to-moderate tension-type or migraine headaches without red flags, the following evidence-based non-pharmacological strategies may help:
**1. Rest in a quiet, dark room**
Reducing sensory stimulation (light and noise) is a foundational step in acute migraine management and can also alleviate tension-type headache.
**2. Cold or warm compress**
Applying a cold pack to the forehead or temples for 15–20 minutes may reduce migraine pain through local vasoconstriction and reduced nerve conduction velocity. Some individuals with tension-type headache prefer a warm compress on the neck and shoulders to relax tense muscles.
**3. Adequate hydration**
Dehydration is a well-recognized headache trigger. A small randomized trial showed that increasing water intake by 1.5 L/day reduced headache intensity and duration in individuals with frequent headaches.
**4. Stress management and relaxation techniques**
Progressive muscle relaxation, deep breathing exercises, and mindfulness-based stress reduction (MBSR) have demonstrated benefit in reducing frequency and intensity of tension-type headache. A Cochrane review found that acupuncture may also be beneficial as a preventive strategy for tension-type headache [7].
**5. Regular sleep hygiene**
Both insufficient and excessive sleep can trigger headaches. Maintaining a consistent sleep-wake schedule (7–9 hours for adults) is generally recommended.
**6. Caffeine — in moderation**
A small amount of caffeine (e.g., 65–200 mg, roughly one to two cups of coffee) can enhance analgesic efficacy and may help relieve headache. However, habitual intake above 200 mg/day increases the risk of caffeine-withdrawal headache and medication-overuse headache.
**7. Peppermint oil**
Topical application of 10% peppermint oil solution to the temples has been shown in small studies to reduce tension-type headache intensity comparably to 1,000 mg acetaminophen.
**8. Limit screen time and optimize ergonomics**
Prolonged screen use and poor posture contribute to eye strain and cervicogenic headache. The 20-20-20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) may reduce associated headaches.
## OTC Medications That Help
Over-the-counter analgesics are first-line pharmacotherapy for episodic tension-type headache and mild-to-moderate migraine. It is critical to limit use to fewer than 10–15 days per month to avoid medication-overuse headache.
| Class | Example | Typical Adult Dose | Notes |
|---|---|---|---|
| **Acetaminophen (paracetamol)** | Tylenol | 500–1,000 mg every 4–6 hours (max 3,000 mg/day; some guidelines allow up to 4,000 mg in healthy adults) | First-line for TTH. Avoid in hepatic impairment or with alcohol use (>3 drinks/day). A Cochrane review confirmed efficacy for episodic TTH (NNT ≈ 10 for pain-free at 2 hours) [4]. |
| **Ibuprofen** (NSAID) | Advil, Motrin | 200–400 mg every 4–6 hours (max 1,200 mg/day OTC) | Effective for both TTH and migraine. Avoid in renal impairment, peptic ulcer disease, or third trimester of pregnancy. Take with food. |
| **Naproxen sodium** (NSAID) | Aleve | 220–440 mg initially, then 220 mg every 8–12 hours (max 660 mg/day OTC) | Longer duration of action than ibuprofen; may be preferred when headache tends to recur. Same GI and renal cautions as ibuprofen. |
| **Aspirin** (NSAID/salicylate) | Bayer, Bufferin | 500–1,000 mg every 4–6 hours (max 4,000 mg/day) | Effective for TTH and migraine. Contraindicated in children and adolescents (risk of Reye syndrome). Avoid with anticoagulants. |
| **Aspirin + acetaminophen + caffeine** | Excedrin Extra Strength | 2 tablets (250 mg aspirin/250 mg APAP/65 mg caffeine) every 6 hours (max 8 tablets/day) | FDA-approved for migraine. A well-powered RCT demonstrated superiority over placebo and individual components for mild-to-moderate migraine [5]. |
> **Caution:** NSAIDs carry cardiovascular (increased risk of MI and stroke with prolonged use), gastrointestinal (ulceration, bleeding), and renal risks. Acetaminophen carries hepatotoxic risk at supra-therapeutic doses. Always read labels and consult a pharmacist or clinician if you take other medications.
## Prescription Options
Prescription therapy is generally warranted when headaches are moderate-to-severe, do not respond to OTC measures, are frequent (≥4 headache days/month for migraine), or significantly impair quality of life.
### Acute (Abortive) Therapies
| Class | Example | Typical Adult Dose | Notes |
|---|---|---|---|
| **Triptans** (5-HT1B/1D agonists) | Sumatriptan (Imitrex), rizatriptan (Maxalt), eletriptan (Relpax) | Sumatriptan 50–100 mg PO; may repeat in 2 hours (max 200 mg/day) | First-line for moderate-to-severe migraine. Contraindicated in uncontrolled HTN, CAD, stroke history. Prescribed by primary care, neurology [5]. |
| **Ergotamine derivatives** | Dihydroergotamine (DHE-45, Migranal nasal spray) | DHE 1 mg IM/SC or nasal spray | Used when triptans fail; same vascular contraindications. Generally prescribed by neurology. |
| **Gepants** (CGRP receptor antagonists) | Ubrogepant (Ubrelvy), rimegepant (Nurtec ODT) | Ubrogepant 50–100 mg PO; rimegepant 75 mg PO | Newer class; no vasoconstrictive effects, so may be used in patients with cardiovascular risk factors. Prescribed by primary care or neurology. |
| **Ditans** (5-HT1F agonists) | Lasmiditan (Reyvow) | 50–200 mg PO | No vasoconstrictive properties; may cause dizziness/sedation. DEA Schedule V. Prescribed by neurology. |
| **Prescription NSAIDs** | Ketorolac (Toradol) | 10 mg PO or 30–60 mg IM (ER setting) | Often used for acute headache in the ED; limited to 5 days due to GI and renal risk. |
| **Antiemetics** | Metoclopramide, prochlorperazine | Varies by agent | Often used as adjuncts or monotherapy for migraine in the ED, especially when nausea is prominent. |
### Preventive (Prophylactic) Therapies
Preventive therapy is generally considered when headaches occur ≥4 days/month, are significantly disabling, or acute medications are overused or contraindicated.
| Class | Example | Typical Adult Dose | Notes |
|---|---|---|---|
| **Beta-blockers** | Propranolol, metoprolol | Propranolol 40–240 mg/day in divided doses | Well-established for migraine prevention. Avoid in asthma, bradycardia. |
| **Tricyclic antidepressants** | Amitriptyline | 10–75 mg at bedtime | Effective for both migraine and TTH prevention. Anticholinergic side effects (dry mouth, sedation, weight gain). |
| **Antiepileptics** | Topiramate, valproate | Topiramate 25–100 mg/day; valproate 500–1,500 mg/day | Topiramate may cause cognitive dulling, weight loss, kidney stones. Valproate is teratogenic — contraindicated in pregnancy. |
| **CGRP monoclonal antibodies** | Erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality) | Erenumab 70–140 mg SC monthly | Newest class with favorable side-effect profile. Prescribed by neurology or headache specialists. |
| **OnabotulinumtoxinA** | Botox | 155–195 units IM across 31–39 injection sites every 12 weeks | FDA-approved only for chronic migraine (≥15 headache days/month). Administered by neurology. |
| **SNRIs** | Venlafaxine | 75–150 mg/day | May be considered for migraine prevention, especially in patients with comorbid depression. |
## Lab Tests Typically Ordered
Headache is primarily a clinical diagnosis. Laboratory and imaging tests are ordered to rule out secondary causes when red flags are present or the headache pattern is atypical.
| Test | Rationale |
|---|---|
| **Complete blood count (CBC)** ([/tests/complete-blood-count](/tests/complete-blood-count)) | Screen for anemia, infection, or hematologic abnormality as a cause of headache |
| **Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)** ([/tests/esr](/tests/esr), [/tests/c-reactive-protein](/tests/c-reactive-protein)) | Elevated in giant cell arteritis; should be ordered in any patient >50 with new-onset headache and temporal tenderness |
| **Basic metabolic panel (BMP)** ([/tests/basic-metabolic-panel](/tests/basic-metabolic-panel)) | Assess renal function, electrolytes, glucose — dehydration, hypoglycemia, or metabolic derangement may cause headache |
| **Thyroid function tests (TSH)** ([/tests/thyroid-stimulating-hormone](/tests/thyroid-stimulating-hormone)) | Hypothyroidism and hyperthyroidism can both contribute to headache |
| **Lumbar puncture (LP)** | Indicated when meningitis, subarachnoid hemorrhage (if CT negative), or idiopathic intracranial hypertension is suspected; measures opening pressure and CSF composition |
| **CT head (non-contrast)** | First-line emergent imaging for thunderclap headache to rule out subarachnoid hemorrhage |
| **MRI brain with/without contrast** | Superior soft-tissue resolution; used to evaluate for mass lesion, cerebral venous sinus thrombosis, Chiari malformation, or posterior fossa pathology |
| **CT/MR angiography** | Evaluates for aneurysm, dissection, or vasculitis when vascular etiology is suspected |
## Special Populations
### Children and Adolescents
Headache is common in children, with prevalence increasing through adolescence. Migraine is the most frequent primary headache disorder requiring medical attention in pediatric patients.
- **Acetaminophen** and **ibuprofen** are first-line OTC treatments. Dosing should be weight-based and guided by a pediatrician or pharmacist — **do not extrapolate adult doses to children**.
- **Aspirin is contraindicated** in children and adolescents under 18 due to the risk of Reye syndrome.
- **Triptans**: Some triptans (e.g., almotriptan for ages ≥12, rizatriptan for ages ≥6) have FDA approval for pediatric use; prescribing should be managed by a pediatric neurologist.
- Non-pharmacological approaches (sleep hygiene, hydration, stress management, limiting screen time) are especially important in this population.
- Children presenting with headache plus vomiting, altered mental status, or progressive worsening require urgent imaging to rule out posterior fossa tumor.
### Pregnancy and Lactation
Headache management during pregnancy requires careful medication selection:
- **Acetaminophen** is generally considered the safest analgesic during pregnancy and is the preferred first-line agent.
- **NSAIDs (ibuprofen, naproxen)**: Generally avoided in pregnancy. May be used with caution in the second trimester under physician supervision, but are **contraindicated in the third trimester** due to risk of premature closure of the ductus arteriosus and oligohydramnios (FDA warning).
- **Aspirin**: Low-dose aspirin (81 mg) may be used for pre-eclampsia prevention as directed by an obstetrician, but analgesic doses should generally be avoided.
- **Triptans**: Limited pregnancy data. Sumatriptan has the most safety data and may be considered when benefits outweigh risks; decision should be made with the prescribing clinician.
- **Ergotamines**: **Absolutely contraindicated** in pregnancy (uterotonic effects).
- **Preventive agents**: Propranolol may be used with caution; topiramate and valproate are **teratogenic and contraindicated**.
- **Red flag**: New or worsening headache in the second or third trimester, especially with hypertension, visual changes, or edema, may indicate **pre-eclampsia** and requires immediate obstetric evaluation.
### Elderly (≥65 years)
- New-onset headache in this age group always warrants thorough evaluation to exclude secondary causes, particularly **giant cell (temporal) arteritis**, mass lesion, subdural hematoma, and medication side effects.
- **NSAID use** carries higher risk of GI bleeding, renal impairment, and cardiovascular events in older adults. Use the lowest effective dose for the shortest duration.
- **Acetaminophen** is generally preferred, but hepatic function should be assessed, and the maximum daily dose may need to be reduced (e.g., ≤2,000 mg/day in frail elderly or those with hepatic impairment).
- **Triptans** should be used with caution due to cardiovascular comorbidities; gepants may offer a safer alternative.
- Polypharmacy is common — always check for drug interactions before adding headache medications.
### Athletes
- **Exertional headache** is common in athletes and is usually benign but should be evaluated at first occurrence to rule out subarachnoid hemorrhage or arterial dissection.
- Adequate hydration, gradual warm-up, and acclimatization to heat and altitude may reduce exertional headaches.
- **Post-concussion headache** is prevalent in contact sports. Athletes with headache following head impact should be immediately removed from play and evaluated per concussion protocols (e.g., SCAT6). Return-to-play decisions should be guided by a sports medicine or concussion specialist.
- NSAIDs and acetaminophen may be used for acute relief; however, frequent use during training periods should be discouraged due to the risk of medication-overuse headache and NSAID-related renal effects during intense exercise.
## When to Escalate
Use the following thresholds to determine the appropriate level of care:
### Call 911 / Go to the Emergency Room
- Thunderclap headache (maximum intensity in <1 minute)
- Headache with fever, neck stiffness, petechial rash
- Headache with neurological deficits (weakness, vision loss, confusion, seizure)
- Headache after significant head trauma, especially with loss of consciousness, repeated vomiting, or worsening drowsiness
- Headache with sudden severe hypertension (systolic >180 mmHg)
- New headache during pregnancy with visual changes or elevated blood pressure
### Same-Day or Next-Day GP / Urgent Care
- New headache pattern that differs significantly from previous headaches
- Headache not responding to usual OTC treatments after 48–72 hours
- Headache accompanied by low-grade fever without clear source
- New headache in a patient over 50
- Headache with jaw claudication or scalp tenderness (suspect giant cell arteritis — temporal artery biopsy should be performed within days)
### Scheduled GP or Neurology Appointment
- Headaches occurring ≥4 days per month and impacting quality of life
- Need for preventive therapy evaluation
- Suspected medication-overuse headache (using acute medications ≥10–15 days/month)
- Headaches not adequately controlled despite appropriate OTC therapy
- Desire for referral to a headache specialist or multidisciplinary pain clinic
> **Disclaimer:** This article is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for guidance tailored to your specific situation.
## References
[1] Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. *Lancet Neurol*. 2018;17(11):954-976. PMID:30353868.
[2] Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. *Cephalalgia*. 2018;38(1):1-211. PMID:29368949.
[3] Bendtsen L, Fernández-de-la-Peñas C. The role of muscles in tension-type headache. *Curr Pain Headache Rep*. 2011;15(6):451-458. PMID:21735049.
[4] Derry S, Wiffen PJ, Moore RA. Aspirin for acute treatment of episodic tension-type headache in adults. *Cochrane Database Syst Rev*. 2017;(1):CD011888. PMID:28084009.
[5] Lipton RB, Stewart WF, Ryan RE, et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. *Arch Neurol*. 1998;55(2):210-217. PMID:9482363.
[6] Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. *Neurology*. 2019;92(3):134-144. PMID:30587518.
[7] Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of tension-type headache. *Cochrane Database Syst Rev*. 2016;(4):CD007587. PMID:27092807.
[8] Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. *Headache*. 2015;55(1):3-20. PMID:25600718.
[9] U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. FDA.gov. 2015. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory.
[10] National Institute for Health and Care Excellence (NICE). Headaches in over 12s: diagnosis and management. Clinical guideline [CG150]. Updated 2021. Available at: https://www.nice.org.uk/guidance/cg150.
